Atlas Trials

Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Clinical trial NCT06069375 · SUSPENDED

Trial details

NCT number
NCT06069375
Sponsor
Jerry Vockley, MD, PhD
Status
SUSPENDED
Phase
Phase 2
Study type
INTERVENTIONAL
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Start date
2024-04-01
Primary completion
2028-06-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.